ArticleHealth services research2026
Provider and Organizational Factors Impacting Routine Cancer Screening Among Older Medicaid Enrollees.
Article in Health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Provider and Organizational Factors Impacting Routine Cancer Screening Among Older Medicaid Enrollees.Health services research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo analyze the conditional association between provider and organizational factors and routine cancer screening for older Medicaid enrollees before and during the COVID-19 pandemic. STUDY SETTING AND
designThis study analyzed pre-pandemic (2018/2019; n = 110,882) and pandemic (2020/2021; n = 107,451) cohorts of New Jersey (NJ) Medicaid enrollees aged 50-75. Using linear probability models, we evaluated how provider and organizational characteristics, including interactions with pandemic years, influenced screening for breast, cervical, colorectal, and lung cancers. Models controlled for enrollees' demographic and clinical characteristics and geographic factors. DATA SOURCES AND ANALYTIC SAMPLE: Claims data from the 2016-2021 NJ Medicaid Management Information System were linked to Medicare Provider and Specialty files. The sample included Medicaid enrollees with an assigned primary care provider and no prior cancer diagnosis. PRINCIPAL
findingsHigher patient panel sizes were consistently associated with increased screening for breast (20.4%, 95% confidence interval (CI): 13.9%-26.8%), cervical (24.1%, 95% CI: 16.6%-31.5%), and lung cancer (63.1%; 95% CI: 17.4%-108.6%) during the pandemic. Obstetrician-gynecologist providers were linked to higher screening rates for breast (50.6%, 95% CI: 41.6%-59.5%) and cervical cancers (70.5%, 95% CI: 52.3%-88.9%), even during the pandemic. Female providers improved screening rates for breast (7.6%, 95% CI: 2.8%-12.3%), cervical (3.8%, 95% CI: 0.10%-7.5%), and colorectal cancer (5.8%, 95% CI: -2.7%-14.4%) among female enrollees. Provider age was unrelated to breast, cervical, or colorectal screening; however, in 2021, lung cancer screening was 23% lower for patients of clinicians aged 62 and above.
conclusionsLarge group practices effectively maintained breast and cervical cancer screening during the pandemic while exhibiting mixed results for colorectal and lung cancers. Provider characteristics such as gender and specialty also significantly impacted screening rates. Supporting large practices and addressing barriers in smaller practices are key to improving cancer prevention, especially during crises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.